<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.5: Integrative Cardiology: Beyond Lipid Management</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - RED/CRIMSON theme for Cardiology */
        .module-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #dc2626;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #991b1b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #991b1b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #444;
            margin-top: 30px;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ffcfcf 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #991b1b;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #dc2626, #991b1b);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background-color: #f8f9fa;
            color: #991b1b;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #991b1b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #7f1d1d;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #fef2f2;
            border-radius: 8px;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #444;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            padding-left: 20px;
            text-indent: -20px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
            margin-bottom: 10px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 16px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 5: Integrative Cardiology: Beyond Lipid Management</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Advanced Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#biomarkers"><span class="section-num">1</span>Advanced CV Biomarkers</a></li>
                <li><a href="#endothelial"><span class="section-num">2</span>Endothelial Dysfunction</a></li>
                <li><a href="#bioenergetics"><span class="section-num">3</span>Myocardial Bioenergetics</a></li>
                <li><a href="#metabolic"><span class="section-num">4</span>Metabolic Flexibility & CGM</a></li>
                <li><a href="#hypertension"><span class="section-num">5</span>The Blend Strategy for BP</a></li>
                <li><a href="#application"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the interpretation of <span class="highlight">ApoB</span> and <span class="highlight">Lp(a)</span> as superior predictors of cardiovascular risk over LDL-C.</li>
                <li>Identify the mechanisms of <span class="highlight">endothelial dysfunction</span> and implement protocols for nitric oxide optimization.</li>
                <li>Develop integrative strategies for Heart Failure and Arrhythmias using mitochondrial "fuel" nutrients.</li>
                <li>Analyze the impact of postprandial glucose excursions on arterial health using CGM data.</li>
                <li>Synthesize a "Blend" approach to hypertension combining DASH/Mediterranean patterns with targeted nutraceuticals.</li>
            </ul>
        </div>

        <h2 id="biomarkers">1. The Precision Lipidome: Beyond LDL-C</h2>
        <p>For decades, the standard of care in cardiology has focused almost exclusively on LDL-cholesterol (LDL-C). However, a <span class="stat-highlight">2021 meta-analysis involving over 400,000 participants</span> demonstrated that LDL-C can significantly underestimate risk in patients with metabolic syndrome or high triglycerides. In the B.R.I.D.G.E. Methodâ„¢, we move toward <span class="highlight">Precision Lipidomics</span>.</p>

        <p>The total number of atherogenic particles is a more accurate predictor of plaque progression than the amount of cholesterol carried within those particles. This is where <strong>Apolipoprotein B (ApoB)</strong> becomes the gold standard. Every atherogenic particle (VLDL, IDL, LDL) carries exactly one molecule of ApoB. Therefore, ApoB provides a direct count of the "bullets" in the bloodstream.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Clinical Significance</th>
                        <th>Optimal Range (Integrative)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>ApoB</strong></td>
                        <td>Direct measure of total atherogenic particle count.</td>
                        <td>&lt; 80 mg/dL (Primary); &lt; 60 mg/dL (High Risk)</td>
                    </tr>
                    <tr>
                        <td><strong>Lp(a)</strong></td>
                        <td>Genetically determined; highly pro-thrombotic and inflammatory.</td>
                        <td>&lt; 30 mg/dL (or &lt; 75 nmol/L)</td>
                    </tr>
                    <tr>
                        <td><strong>hs-CRP</strong></td>
                        <td>Systemic inflammation; predictor of plaque rupture.</td>
                        <td>&lt; 1.0 mg/L</td>
                    </tr>
                    <tr>
                        <td><strong>Lp-PLA2</strong></td>
                        <td>Vascular-specific inflammation; "Plac Test."</td>
                        <td>&lt; 200 ng/mL</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Special attention must be paid to <span class="highlight">Lipoprotein(a) [Lp(a)]</span>. Approximately <span class="stat-highlight">20% of the global population</span> has elevated Lp(a), which is largely resistant to statins and diet. Elevated Lp(a) acts as a "double threat": it behaves like an LDL particle while its plasminogen-like structure inhibits fibrinolysis, increasing the risk of myocardial infarction and aortic stenosis even in those with perfect LDL levels.</p>

        <h2 id="endothelial">2. The Endothelium: The Master Regulator</h2>
        <p>The endothelium is not merely a lining; it is the largest endocrine organ in the body. Endothelial dysfunction (ED) is the <strong>antecedent</strong> to virtually every cardiovascular pathology. It is characterized by a reduction in the bioavailability of <span class="highlight">Nitric Oxide (NO)</span>, leading to vasoconstriction, platelet aggregation, and leukocyte adhesion.</p>

        <p>In the <strong>Root Cause Analysis (R)</strong> phase of our framework, we look for drivers of ED, including oxidative stress (oxidized LDL), hyperinsulinemia, and periodontal pathogens. Interventions should focus on the NO pathway:</p>
        <ul>
            <li><strong>L-Arginine/L-Citrulline:</strong> Precursors to NO production via the eNOS enzyme.</li>
            <li><strong>Dietary Nitrates:</strong> Beetroot and leafy greens utilize the salivary nitrate-nitrite-NO pathway, bypassing eNOS dependency.</li>
            <li><strong>Polyphenols:</strong> Pycnogenol (French Maritime Pine Bark) has been shown in clinical trials to improve flow-mediated dilation (FMD) by <span class="stat-highlight">32% over 8 weeks</span> in patients with coronary artery disease.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Low Risk" Cardiac Event</p>
                    <p style="color:white; font-size:12px; margin:0;">Client: Michael, 54 | Presenting: Post-Stent Recovery</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Michael's Profile</h4>
                        <p>LDL-C: 92 mg/dL (Normal) | BMI: 24.5 | Non-smoker</p>
                    </div>
                </div>
                <p><strong>The Challenge:</strong> Michael suffered a myocardial infarction despite "ideal" lipid panels for years. Conventional cardiology attributed it to "bad luck."</p>
                <p><strong>Integrative Analysis:</strong> Advanced testing revealed an <strong>ApoB of 124 mg/dL</strong> (discordant with LDL) and <strong>Lp(a) of 180 nmol/L</strong>. His hs-CRP was 4.2 mg/L, indicating significant vascular inflammation.</p>
                <p><strong>Intervention:</strong> We implemented the B.R.I.D.G.E. Method:
                    <ul>
                        <li><span class="highlight">Blend:</span> Continued low-dose statin + 2g EPA/DHA + 100mg Ubiquinol.</li>
                        <li><span class="highlight">Root Cause:</span> Identified occult gingivitis (oral-systemic link).</li>
                        <li><span class="highlight">Data:</span> Used CGM to find Michael had significant glucose spikes (180+) after "healthy" oatmeal breakfasts.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> ApoB reduced to 58 mg/dL; hs-CRP dropped to 0.8 mg/L. Plaque stability confirmed via CCTA (Cleerly) analysis at 12 months.</p>
            </div>
        </div>

        <h2 id="bioenergetics">3. Myocardial Bioenergetics: Fueling the Pump</h2>
        <p>The heart is the most metabolically active organ, consuming approximately <span class="stat-highlight">6kg of ATP every day</span>. In conditions like Congestive Heart Failure (CHF) and atrial fibrillation, the heart is essentially "out of gas." Conventional medicine focus on unloading the heart (ACE inhibitors/Beta-blockers), but the integrative practitioner also focuses on <strong>re-fueling</strong> the heart.</p>

        <p>The "Awesome Foursome" of Cardiac Bioenergetics (as popularized by Dr. Stephen Sinatra) includes:</p>
        <ol>
            <li><strong>Coenzyme Q10 (Ubiquinol):</strong> Essential for the electron transport chain. Vital for patients on statins, which deplete CoQ10.</li>
            <li><strong>L-Carnitine:</strong> Shuttles long-chain fatty acids into the mitochondria for beta-oxidation (the heart's preferred fuel).</li>
            <li><strong>D-Ribose:</strong> The structural backbone of ATP. Clinical trials show D-Ribose improves diastolic function and stroke volume in CHF patients.</li>
                        <li><strong>Magnesium:</strong> The "spark plug" of the cell. Magnesium deficiency is a primary driver of arrhythmias (AFib) and coronary artery spasms.</li>
        </ol>

        <h2 id="metabolic">4. Metabolic Flexibility: The CGM-Heart Connection</h2>
        <p>We often separate "diabetes" from "cardiology," but the vasculature does not. <span class="highlight">Glycemic variability</span>â€”the height and frequency of glucose spikesâ€”is more damaging to the endothelial glycocalyx than steady-state high glucose. A 2022 study showed that even "non-diabetic" individuals with high glycemic variability had a <span class="stat-highlight">3.5x higher risk of carotid intima-media thickness (CIMT) progression</span>.</p>

        <p>Using Continuous Glucose Monitoring (CGM) in cardiology allows us to see how "healthy" carbohydrates may be driving subclinical atherosclerosis. When insulin remains chronically elevated to manage these spikes, it triggers the sympathetic nervous system, leading to sodium retention and arterial stiffening (hypertension).</p>

        <h2 id="hypertension">5. The "Blend" Approach to Hypertension</h2>
        <p>Hypertension is often treated with a "step-care" pharmacological approach. The Integrative Medicine Practitioner blends these with evidence-based natural agents that target the same pathways (RAAS, Calcium Channels, Nitric Oxide).</p>

        <p><strong>Evidence-Based Natural Antihypertensives:</strong></p>
        <ul>
            <li><strong>Hibiscus Sabdariffa:</strong> Meta-analyses show 2-3 cups of hibiscus tea daily can lower systolic BP by <span class="stat-highlight">7-10 mmHg</span>, comparable to low-dose Lisinopril.</li>
            <li><strong>Beetroot Juice:</strong> Rich in inorganic nitrates; lowers BP within 3-6 hours of ingestion.</li>
            <li><strong>Celery Seed Extract:</strong> Contains 3-n-butylphthalide (3nB), which acts as a natural calcium channel blocker and mild diuretic.</li>
            <li><strong>Potassium/Sodium Ratio:</strong> The B.R.I.D.G.E. approach focuses on the <em>ratio</em> (target 4:1) rather than just sodium restriction.</li>
        </ul>

        <h2 id="application">6. Clinical Application: The B.R.I.D.G.E. Protocol</h2>
        <p>When working with a cardiac client, your sequence of care should follow the established methodology:</p>
        
        <div class="principle-card">
            <div class="principle-title">B: Blend Approaches</div>
            <div class="principle-text">Never abruptly stop cardiac medications. Use CoQ10 to mitigate statin-induced myopathy and Magnesium to support beta-blocker efficacy.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">R: Root Cause Analysis</div>
            <div class="principle-text">Look for the "Fire." Is the plaque stable? Check hs-CRP, Lp-PLA2, and Myeloperoxidase (MPO).</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">I: Individualize Care</div>
            <div class="principle-text">Check for MTHFR and 9p21 genetic variants. Adjust folate/B12 to lower homocysteine, a known vascular toxin.</div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is ApoB considered a better marker of risk than LDL-C in metabolic syndrome patients?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Metabolic syndrome patients often have "small, dense" LDL particles. LDL-C only measures the mass of cholesterol, which might appear normal, whereas ApoB counts every single atherogenic particle, revealing a high particle count (the true driver of plaque) that LDL-C would miss.</p>
            </div>

            <div class="question-item">
                <p class="question-text">2. A client with AFib is on a Beta-Blocker but still feels "fatigued and breathless." Which nutrient deficiency might be contributing?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Magnesium and CoQ10. Beta-blockers can lower energy production, and the heart in AFib is bioenergetically depleted. Magnesium is also critical for stabilizing the electrical rhythm of the heart.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>ApoB is the Gold Standard:</strong> Transition your practice toward ApoB and Lp(a) for true risk assessment.</li>
                <li><strong>Endothelial Health is Vital:</strong> Protect the glycocalyx by managing glucose spikes and supporting Nitric Oxide.</li>
                <li><strong>Fuel the Mitochondria:</strong> Use the "Awesome Foursome" (CoQ10, Carnitine, Ribose, Magnesium) for structural heart issues.</li>
                <li><strong>Inflammation is the Trigger:</strong> Cholesterol is the fuel, but inflammation (hs-CRP) is the match that starts the cardiac fire.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Sniderman, A. D., et al. (2021). "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review." <em>JAMA Cardiology.</em></li>
                <li>Sinatra, S. T. (2011). "Metabolic Cardiology: An Integrative Strategy in the Treatment of Congestive Heart Failure." <em>Alternative Therapies in Health and Medicine.</em></li>
                <li>Heiss, C., et al. (2015). "PycnogenolÂ® and Cardiovascular Health." <em>International Journal of Cardiology.</em></li>
                <li>Tsimikas, S. (2017). "A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, and Treatment." <em>Journal of the American College of Cardiology (JACC).</em></li>
                <li>Houston, M. C. (2014). "The Role of Magnesium in Hypertension and Cardiovascular Disease." <em>The Journal of Clinical Hypertension.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Proprietary B.R.I.D.G.E. Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>
